Literature DB >> 26137126

Focal adhesion kinase is involved in the migration of human osteosarcoma cells.

Sitan Feng1, Xin Shi2, K E Ren3, Sujia Wu2, Xiaoliang Sun3.   

Abstract

The aim of the present study was to analyze the expression of focal adhesion kinase (FAK) in osteosarcoma (OS) cell lines with different migration abilities in order to determine the role of FAK in migration. A number of different 143B subclone cell lines (A1, A2, A3, A4 and A5) were obtained by a limiting dilution method, and the expression of FAK was detected using western blot analysis. The role of FAK in the migration of OS cells was investigated using small interfering RNA (siRNA), and the ratio of the number of lamellipodia was compared by immunofluorescence staining. The A2 and A3 OS 143B subclone cell lines demonstrated a stronger migration ability and exhibited higher FAK expression compared with the A1 cell line (P<0.05). Following transfection with FAK-siRNA, the migration ability of the A3 cells was significantly decreased (P<0.05), and the ratio of the number of lamellipodia formed was reduced from 35 to 11% (P<0.05). In conclusion, the level of FAK expression was higher in the cell lines with a stronger migration ability. FAK affects the migration ability of OS cells by suppressing the formation of lamellipodia.

Entities:  

Keywords:  focal adhesion kinase; lamellipodia; migration; osteosarcoma; subclone cell lines

Year:  2015        PMID: 26137126      PMCID: PMC4473501          DOI: 10.3892/ol.2015.3131

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  15 in total

1.  Phosphorylation of focal adhesion kinase at Tyr397 in gastric carcinomas and its clinical significance.

Authors:  I-Rue Lai; Pei-Yu Chu; Hsiao-Sheng Lin; Jun-Yang Liou; Yee-Jee Jan; Jen-Chieh Lee; Tang-Long Shen
Journal:  Am J Pathol       Date:  2010-08-19       Impact factor: 4.307

2.  Fifty years of paediatric malignant bone tumours in the West Midlands, UK, 1957-2006: incidence, treatment and outcome.

Authors:  S E Parkes; S Parke; D C Mangham; R J Grimer; P Davies; B J Morland
Journal:  Paediatr Perinat Epidemiol       Date:  2010-09       Impact factor: 3.980

3.  The many faces of osteosarcoma.

Authors:  M D Murphey; M R Robbin; G A McRae; D J Flemming; H T Temple; M J Kransdorf
Journal:  Radiographics       Date:  1997 Sep-Oct       Impact factor: 5.333

4.  The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity.

Authors:  M P Link; A M Goorin; A W Miser; A A Green; C B Pratt; J B Belasco; J Pritchard; J S Malpas; A R Baker; J A Kirkpatrick
Journal:  N Engl J Med       Date:  1986-06-19       Impact factor: 91.245

5.  FAK is involved in invasion and metastasis of hepatocellular carcinoma.

Authors:  Jing-Song Chen; Xiao-Hui Huang; Qian Wang; Xi-Lin Chen; Xin-Hui Fu; Hao-Xiang Tan; Long-Juan Zhang; Wen Li; Jiong Bi
Journal:  Clin Exp Metastasis       Date:  2010-02-24       Impact factor: 5.150

Review 6.  Focal adhesion kinase as a cancer therapy target.

Authors:  Vita M Golubovskaya
Journal:  Anticancer Agents Med Chem       Date:  2010-12       Impact factor: 2.505

7.  Cancer cell invasion and metastasis.

Authors:  L A Liotta
Journal:  Sci Am       Date:  1992-02       Impact factor: 2.142

Review 8.  Osteosarcoma.

Authors:  Patrick J Messerschmitt; Ryan M Garcia; Fadi W Abdul-Karim; Edward M Greenfield; Patrick J Getty
Journal:  J Am Acad Orthop Surg       Date:  2009-08       Impact factor: 3.020

Review 9.  Opportunities for improving the therapeutic ratio for patients with sarcoma.

Authors:  Jay S Wunder; Torsten O Nielsen; Robert G Maki; Brian O'Sullivan; Benjamin A Alman
Journal:  Lancet Oncol       Date:  2007-06       Impact factor: 41.316

10.  Endothelial FAK is required for tumour angiogenesis.

Authors:  Bernardo Tavora; Silvia Batista; Louise E Reynolds; Shalini Jadeja; Stephen Robinson; Vassiliki Kostourou; Ian Hart; Marcus Fruttiger; Maddy Parsons; Kairbaan M Hodivala-Dilke
Journal:  EMBO Mol Med       Date:  2010-12       Impact factor: 12.137

View more
  2 in total

1.  Overexpression of CD155 relates to metastasis and invasion in osteosarcoma.

Authors:  Baobiao Zhuo; Yuan Li; Feng Gu; Zhengwei Li; Qingzeng Sun; Yingchun Shi; Yang Shen; Fengfei Zhang; Rong Wang; Xiaodong Wang
Journal:  Oncol Lett       Date:  2018-03-09       Impact factor: 2.967

Review 2.  Targeting protein kinases to reverse multidrug resistance in sarcoma.

Authors:  Hua Chen; Jacson Shen; Edwin Choy; Francis J Hornicek; Zhenfeng Duan
Journal:  Cancer Treat Rev       Date:  2015-12-08       Impact factor: 12.111

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.